Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program. Go to Publication You Might Also Like High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. March 15, 2005 Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us January 9, 2020 Therapeutic choices in rifampicin-resistant tuberculosis. November 16, 2016 Prescriptions for tuberculosis treatment: get it right the first time. April 9, 2011 Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016
High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. March 15, 2005
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us January 9, 2020
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016